Expression analysis of IGFBP-3 using human whole-genome microarray.

Slides:

Advertisements

Similar presentations

Normal Distribution.

Advertisements

PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.

A, Effect of folate-FITC (500 nmol/kg, 5 days/week) and/or sunitinib (20 mg/kg daily) therapy on the growth of M109 tumors in Balb/c mice. A, Effect of.

CD25 expression is associated with unfavorable clinical outcome.

Correlation of log-transformed signal intensity from two Affymetrix microarray hybridizations using platelet RNA. Plotted are those probesets with an average.

Whole-exome sequencing identifies NF1 mutations in tumors of melanoma patients exhibiting resistance to vemurafenib. Whole-exome sequencing identifies.

Kenshi Hayashi et al. JACEP 2016;2:

Chromosome 8 cDNA microarray gene expression profile of the amplified regions of 8p11–12 in SUM-44, -52, and -225 cells versus MCF10A HME control cells.

Toray microarray analysis of the four groups of patients (A) and in patients with calcium score >100 (B). Toray microarray analysis of the four groups.

DNMT3A2 signatures are coherently modified in AML.

Computed tomographic images from a patient with BRAFL597S-mutant metastatic melanoma responding to therapy with the MEK inhibitor TAK-733. Computed tomographic.

MMAE resistance and intracellular accumulation.

Whole-genome microarray analysis of gene expression in the livers of control mice and STAM mice subjected to NASH-derived hepatocarcinogenesis. Whole-genome.

Figure 3. Sensitivity and specificity of microarray analysis in relation to target number Sensitivity and specificity of microarray analysis in relation.

Changes in tumor sizes, CA-125, serum ceruloplasmin, and copper levels in 5 patients with platinum-resistant high-grade epithelial ovarian cancer who received.

GA blocks HIF activity and reduces HIF target expression.

Log faecal calprotectin concentration (mg/l) in the different diagnostic groups. Log faecal calprotectin concentration (mg/l) in the different diagnostic.

A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.

Immunohistochemical analyses of SHH expression levels in nonmalignant prostate and adenocarcinoma tissues. Immunohistochemical analyses of SHH expression.

Diagnostic plots of the TGI PKPD model fitted to the A677 TGI data.

The expression of SPINDLIN1 in cancer tissues.

Skin tumor size following ligand activation of PPARβ/δ and inhibition of COX2. Skin tumor size following ligand activation of PPARβ/δ and inhibition of.

C-MYC controls expression of ABC drug transporters in CD34+ hematopoietic progenitors. c-MYC controls expression of ABC drug transporters in CD34+ hematopoietic.

Leukemic blasts express a “hypoxia signature

Effect of HA on hematopoietic recovery in tumor-bearing mice.

PTENP1 sensitizes renal cancer cells to chemotherapy.

GS87 demonstrates efficacy in a circulating AML mouse model system.

NSG mice transplanted with human primary ALK-positive ALCL tumor grafts were administered either doxorubicin, 10 mg/kg i.v. or CEP orally, 100 mg/kg,

Integrated mRNA and microRNA expression and DNA methylation clusters.

Tlr4−/− attenuates symptomatic parameters of gut toxicity: diarrhea and weight loss. Tlr4−/− attenuates symptomatic parameters of gut toxicity: diarrhea.

PD-L1 expression correlates with T-cell markers and an IFN response signature in human melanomas. PD-L1 expression correlates with T-cell markers and an.

CD94/NKG2A+ TILs lack tissue resident CD103 marker.

Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,

Immune signatures of patients with short-, medium-, and long-term survival. Immune signatures of patients with short-, medium-, and long-term survival.

CAT displays very high in vivo stability as exemplified by a rat PK study. CAT displays very high in vivo stability as exemplified by a rat.

AXL is not expressed in human prostate tumors.

Pre- and post-vorinostat values of ER-related gene expression using the Oncotype DX 21-gene assay. Pre- and post-vorinostat values of ER-related gene expression.

TDP1 and TOP1 protein levels vary widely in colorectal cancer (CRC) patient samples. TDP1 and TOP1 protein levels vary widely in colorectal cancer (CRC)

Time to onset of hypothyroidism after first treatment with immune checkpoint inhibitors in the combination therapy and monotherapy groups. Time to onset.

Immunohistochemical detection of nuclear and cytoplasmic YB-1 in osteosarcoma and synovial sarcoma. Immunohistochemical detection of nuclear and cytoplasmic.

Kaplan–Meier curves for PFS and OS (for patients treated with anti-PD-1/PD-L1 monotherapy). Kaplan–Meier curves for PFS and OS (for patients treated with.

Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in.

Angiogenesis in tumors formed by cells varying in the expression of CXCR2. Angiogenesis in tumors formed by cells varying in the expression of CXCR2. A,

Positions of the EGFR exon 20 insertions identified over a 3-year period and comparison with the spectrum of EGFR exon 19 and HER2 insertion mutations.

Src expression in a panel of human TCC cell lines.

Immunohistochemical analysis of dUTPase in human breast adenocarcinoma

Discovered and replicated positive correlation between miR-193b

Microarray analysis of global gene expression profiles of PC-3 and derivative cell lines. Microarray analysis of global gene expression profiles of PC-3.

Tumor and serum levels of murine IL-12.

Expression of S100A11 in bulk pancreatic tissues (pancreatic cancer, n = 22; IPMN, n = 18; nonneoplastic pancreas, n = 22). Expression of S100A11 in bulk.

Consistency of conversion of GR to urinary ITC in 3 high converter phenotypes who were tested on 5 to 7 occasions (selected from the 131 determinations.

Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.

Immunohistochemical staining for FOXO3a of breast cancer tumor tissues

Influence of ASGR2 expression on survival.

Osteoactivin is overexpressed in aggressively bone metastatic 4T1 subpopulations versus weakly bone metastatic breast cancer populations. Osteoactivin.

Increased frequency and number of KLL-specific clonotypes in tumors is associated with improved MCC-specific survival. Increased frequency and number of.

Monocytes from melanoma patients are unresponsive to TLR3 agonists.

Genomic determinants of response to cytotoxic chemotherapy.

A summary of the average level of methylation of selected MCA/RDA MICPs by bisulfite-modified genomic sequencing. A summary of the average level of methylation.

Antigen expression and Breslow thickness.

JAK3 mutations and ectopic expression of HOXA9 are significantly associated in clinical T-ALL cases. JAK3 mutations and ectopic expression of HOXA9 are.

In vivo shRNA screening in PDXs from 3 patients with melanoma.

Integrated analysis of gene expression and copy number alterations.

Highly metastatic PDAC cells have a unique gene signature, which is not preserved in metastases but predicts poor patient outcome. Highly metastatic PDAC.

Overexpression of SUFU and GLI1 in the poor clinical outcome subgroup was confirmed by real-time PCR along with its association with disease progression.

PD-L1 expression is not associated with PTEN expression status in melanomas. PD-L1 expression is not associated with PTEN expression status in melanomas.

Isolation of large soft agar clones from HBEC3p53,KRAS and HBEC3p53,KRAS,MYC identifies tumorigenic and nontumorigenic clones and genome-wide mRNA expression.

© The Author(s) Published by Science and Education Publishing.

Table 4. Independent Samples Test Application of ICT by Gender

Treatment with octyl-D-2-HG and octyl-L-2-HG reduces MIR148A expression. Treatment with octyl-D-2-HG and octyl-L-2-HG reduces MIR148A expression. A, Treatment.

Presentation transcript:

Expression analysis of IGFBP-3 using human whole-genome microarray. Expression analysis of IGFBP-3 using human whole-genome microarray. The average expression level of IGFBP-3 in metastatic melanoma patient samples (n = 30) was significantly higher (Wilcoxon test with two-tailed probability, P = 0.0005; 95% confidence interval for the median, 0.7592–2.5170) than primary melanoma patient samples (n = 14; 95% confidence interval for the median, 0.4005–0.9653). Yaguang Xi et al. Mol Cancer Ther 2006;5:3078-3084 ©2006 by American Association for Cancer Research